The Daily Folgen

Nearly a decade after the devastation of Hurricane Sandy, which destroyed piers and damaged riverside social housing projects, residents of Lower Manhattan are still vulnerable to floods.Michael Kimmelman, The Times’s architecture critic, explores the nine-year effort to redesign Lower Manhattan in the wake of the hurricane, and the design and planning challenges that have made progress incremental. He goes inside a fight over how to protect the neighborhood in the future — revealing why renewal in the face of climate disaster is so complicated.This story was narrated by Michael Kimmelman. To hear more audio stories from publications like The New York Times, download Audm for iPhone or Android.The Headway initiative is funded through grants from the Ford Foundation, the William and Flora Hewlett Foundation and the Stavros Niarchos Foundation (SNF), with Rockefeller Philanthropy Advisors serving as a fiscal sponsor. The Woodcock Foundation is a funder of Headway’s public square.The New York Times works with philanthropic organizations that share its belief that editorial independence is crucial to the power and value of its journalism. Funders have no control over the selection, focus of stories or the editing process and do not review stories before publication. The Times retains full editorial control of the Headway initiative.  Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

The Omicron variant of the coronavirus is incredibly contagious — it is able to infect people with even greater frequency than the Delta variant, and it is skilled at evading the immune system’s defenses. Much is still unknown about the new variant, and scientists are racing to understand its threat. But amid the uncertainty, there’s good news about a prospective new virus treatment: A pill by Pfizer is effective in reducing people’s risk of hospitalization or death from Covid-19.We explore these two developments and what they could mean for the next phase of the pandemic.Guest: Carl Zimmer, a science writer and author of the “Matter” column for The New York Times.Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. Background reading: An Omicron surge is likely. Here’s what to expect.Pfizer announced that its Covid pill was found to stave off severe disease in a key clinical trial and that it is likely to work against the highly mutated Omicron variant of the virus.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.  Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

Anti-abortion activists across the country are optimistic that they might be on the cusp of achieving a long-held goal of the movement: overturning Roe v. Wade, the 1973 Supreme Court decision that extended federal protections for abortion.But many abortion rights activists are hopeful, too. They are watching closely to see whether the Food and Drug Administration will roll back restrictions on one medication, transforming abortion access across the country. Today, we explore the future of America’s abortion fight.Guest: Pam Belluck, a health and science writer for The New York Times.Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. Background reading: Who gets abortions in America? Here’s what we know.During the pandemic, health care providers can send abortion medication by mail. Will the courts allow that to continue?For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.  Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.